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Interleukin-4 is a cytokine widely known for its role in CD4+ T cell
polarization and its ability to alternatively activate macrophage
populations. In contrast, the impact of IL-4 on the activation and
function of dendritic cells (DCs) is poorly understood. We report
here that DCs respond to IL-4 both in vitro and in vivo by expres-
sion of multiple alternative activation markers with a different
expression pattern to that of macrophages. We further demon-
strate a central role for DC IL-4Rα expression in the optimal in-
duction of IFNγ responses in vivo in both Th1 and Th2 settings,
through a feedback loop in which IL-4 promotes DC secretion of
IL-12. Finally, we reveal a central role for RELMα during T-cell
priming, establishing that its expression by DCs is critical for opti-
mal IL-10 and IL-13 promotion in vitro and in vivo. Together, these
data highlight the signiﬁcant impact that IL-4 and RELMα can have
on DC activation and function in the context of either bacterial or
helminth pathogens.
antigen presenting cells | T lymphocytes | innate immunity |
adaptive immunity
Activation of dendritic cells (DCs) with bacterial or viral an-tigen (Ag) results in production of proinﬂammatory cyto-
kines and enhanced ability to stimulate Th1/Th17 responses (1).
In addition, a range of cytokines inﬂuence DC activation, with
IL-12 and IL-10 playing critical roles in either promotion or
regulation of DC maturation and function (2, 3). The hallmark
of allergic disease and helminth infection is induction of a CD4+
Th2 response, characterized by secretion of cytokines such as IL-
4 and IL-13 (4). Although DCs themselves are not thought to
produce IL-4 (5), this canonical Th2 cytokine can be secreted
rapidly in direct response to pathogen stimulation by a variety of
other innate cells (4). As such, DCs encountering Ag or patho-
gen stimulation in Th2 infection or disease settings will likely be
simultaneously exposed to IL-4. However, the impact of IL-4 on
the functional capability of DCs remains relatively unexplored.
In comparison with DCs, the effect of IL-4 on activation of
macrophage (MΦ) populations has been much more thoroughly
addressed, with IL-4/IL-13 treatment resulting in “alternatively”
activated macrophages (aaMΦs) (6) characterized by the ex-
pression of Arginase-1, chitinase-like molecule Ym1, resistin-like
molecule α (RELMα, also known as FIZZ1), and C-type lectin
receptors such as mannose receptor (MR) and Dectin-1 (6, 7).
Although the individual and cumulative function of these IL-4–
induced products is not clear, aaMΦs are thought to play vital
roles in helminth infection and tissue remodeling, and are capable
of suppressing T-cell responses (8–10). However, only a limited
number of studies have addressed whether DCs express markers
associated with aaMΦs (11–14), and it remains unclear how ex-
pression of IL-4–induced molecules may inﬂuence DC function in
Th2 settings. Somewhat surprisingly, previous work has indicated
that IL-4 can enhance production of IL-12p70 by DCs stimulated
with bacterial LPS in vitro via inhibition of IL-10 (15–18). This
suggests that IL-4 may facilitate DC priming of Th1 responses in
ongoing, counterregulatory, Th2 settings (15, 16, 19).
We set out to delineate the role of IL-4 in inﬂuencing DC
activation and function, both in vitro and in vivo. We show that
treatment of DCs with IL-4 in vitro resulted in robust expression
of a wide range of alternative activation markers at both the
transcript and protein level, with a more selective expression
of alternative activation markers RELMα and Ym1 in vivo.
We further demonstrate a key role for DC-derived RELMα in
promotion of optimal Th2 responses that contrasts with the
previously suggested regulatory function of this alternative acti-
vation product (20–22). Together, these data reveal that the
ability to respond to IL-4 is critical for optimal Th1 or Th2
priming by DCs through modulation of IL-12/IL-10 or RELMα
production, respectively.
Results
IL-4 Induces DC Expression of RELMα in Vivo. The phenotypes of
aaMΦ populations, isolated from a variety of tissues in Th2 in-
ﬂammatory settings, have been well characterized, with one hall-
mark being the abundant expression of markers RELMα and Ym1
(6). RELMα has also previously been identiﬁed in cells other than
aaMΦs, including eosinophils and epithelial cells (10, 20, 22). To
investigate whether DCs respond to Th2 environments in a manner
similar to MΦs, mice were injected i.p. with rIL-4 complexed with
anti–IL-4 mAb (IL-4c), which ensures slow release of cytokine for
2–3 d (23). Peritoneal exudate cells (PEC) were isolated 4 d after
mice received a single dose of IL-4c or PBS. For ﬂow-cytometric
analysis, granulocytes, monocytes, and B cells were excluded (based
on cell size, Gr1, and CD19 staining), MΦs were deﬁned as F4/
80+FSCint/hiMHC-IIlo/int and DCs as F4/80−FSCloCD11chiMHC-
IIhi (Fig. 1A). IL-4c did not signiﬁcantly alter the number of DCs in
the PEC but, as recently reported (23), signiﬁcantly increased ac-
cumulation of MΦs (P < 0.05; Fig. 1A), suggesting that, in contrast
to MΦs, DCs do not proliferate in response to IL-4c injection. To
assess whether IL-4 administration caused alternative activation of
these populations, we performed intracellular staining for RELMα
and Ym1/2. As expected, MΦs isolated from IL-4c–injected mice
displayed striking levels of RELMα and Ym1/2 expression com-
pared with MΦs isolated from PBS control animals (Fig. 1B).
Furthermore, the expression of these proteins was not uniform,
with RELMα+Ym1/2−, RELMα+Ym1/2+, and RELMα−Ym1/2+
MΦ populations all being identiﬁed. In contrast to the effect on
MΦs, predominantly single positive RELMα−expressing DCs were
observed at a low dose of IL-4c (0.6 μg) with little change in Ym1/2
evident. However, at a higher dose of IL-4c (4 μg), a signiﬁcant
proportion of RELMα-positive DCs expressed Ym1/2. In addition,
the ability to respond to IL-4 in vivo was not restricted to peri-
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toneal cavity DCs, as splenic MHCIIhiCD11chi DCs also signiﬁ-
cantly up-regulated RELMα and Ym1/2 expression following IL-4c
injection (Fig. S1).
To determine the general capacity of DCs to alternatively
activate in vivo in response to stimuli other than IL-4c, we
assessed RELMα and Ym1/2 production by DCs from mice
infected with Litomosoides sigmodontis or Schistosoma mansoni
(Fig. S2), parasitic helminths that promote strong Th2 responses.
Pleural cavity (Fig. S2A) or splenic (Fig. S2B) MHCIIhiCD11chi
DCs from infected mice displayed signiﬁcantly increased ex-
pression of RELMα in comparison with naive control animals.
Ym1/2 expression was less dramatically inﬂuenced by infection
(Fig. S2). Thus, DCs from diverse tissue sites can express
markers associated with aaMΦs in vivo, in response to injection
with IL-4c or in the more complex setting of helminth infection.
IL-4 Up-Regulates DC Expression of Multiple Markers of Alternative
Activation. To carefully dissect the inﬂuence of IL-4 on a well-
characterized population of cells, we generated DCs from murine
bone marrow (BM) using GM-CSF, then exposed the DCs to
recombinant IL-4 in vitro. As shown previously, DCs expressed IL-
4Rα (Fig. 2A) (18), and IL-4 did not substantially alter MHC-II or
the costimulatory molecules CD40, CD80 and CD86 (Fig. S3).
However, IL-4 signiﬁcantly increased DC mRNA levels and pro-
tein secretion of both RELMα (Retnla) and Ym1/2 (Chi3l3) (Fig.
2 B and C). Intracellular staining showed that production of these
Fig. 1. IL-4c induces MΦ and DC expression of RELMα in vivo. MΦs and DCs in PEC from PBS- or IL-4c–treated mice were assessed by ﬂow cytometry (A). MΦs
and DCs as deﬁned in (A) stained for intracellular expression of RELMα and Ym1/2 (B). Data are representative of ﬁve experiments. Graphs show percent
expression for individual mice, three to ﬁve per group. FMO, ﬂuorescence minus one control.
Fig. 2. IL-4 stimulates RELMα and Ym1 expression by BMDCs. IL-4Rα expression by BMDCs (A) (shaded portion = isotype control; black line = media; gray line= +IL-
4). WT or Il4ra−/− BMDCs were cultured overnight with or without IL-4 and were assessed for markers of alternative activation (B–F) (black = without IL-4; gray = 20
ng/mL IL-4). Data are representative of more than three experiments. Error bars indicate SEM of triplicate wells. a.u., Arbitrary units.
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proteins was not limited to a single population, with both RELMα
and Ym1/2 single and double-positive DCs clearly distinguishable
(Fig. 2D: WT). Verifying that DC up-regulation of RELMα and
Ym1/2 was a consequence of IL-4 responsiveness, Il4ra−/−DCs did
not up-regulate RELMα and Ym1/2 in response to IL-4 (Fig. 2D:
Il4ra−/−). In addition, in WT DCs, IL-4 increased transcripts for
Dectin-1 (Clec7a), Mrc1 (MR) and Ccl24 (Fig. 2E), markers
previously associated with aaMΦs (6, 7). However, Arginase-1,
another signature molecule of aaMΦs (6), was not signiﬁcantly
increased in terms of either transcription or enzymatic activity in
IL-4–treated DCs (Fig. 2F). Increased transcript expression of
Retnla, Clec7a, and Ccl24 was also seen following in vitro exposure
of FACS-puriﬁed splenic cDCs from naive mice to IL-4 (Fig. S4).
Together, these data reveal that murine DCs can respond to IL-4
in a manner similar to that previously described for aaMΦs by
signiﬁcantly up-regulating RELMα and Ym1/2 and other aaMΦ
markers, with the notable exception of Arginase-1.
Signaling to DCs via IL-4Rα Alters Their Response to Inﬂammatory
Stimuli and Is Important for Their Ability to Induce IFNγ and IL-17.
Previous studies have shown that IL-4 can boost DC proin-
ﬂammatory cytokine production upon engagement of speciﬁc
pattern recognition receptors, and suggested that this may rep-
resent a mechanism to enable DC induction of adaptive Th1
responses in IL-4–rich environments (15, 19). We assessed the
inﬂuence of IL-4 on DCs exposed to IL-4 concurrently with
complex Ag from pathogens and individual toll like receptor
(TLR) ligands. We found that DC exposure to ligands of TLR4
(LPS), TLR9 (CpG), or a heat-killed preparation of the Gram-
positive bacterium Propionibacterium acnes (Pa) boosted IL-12p70
secretion, and inhibited production of IL-10, RELMα, and Ym1/
2, in response to IL-4 (Fig. S5 A–D). Production of proin-
ﬂammatory cytokines IL-1β and IL-6 was not signiﬁcantly altered
by IL-4 treatment (Fig. S5E). In contrast to Pa and TLR ligands,
DCs exposed to soluble extracts from the egg stage of S. mansoni
[soluble egg Ag (SEA)] in the presence or absence of IL-4 did not
alter secretion of either RELMα or Ym1/2, indicating that SEA
has no potential to drive or block alternative activation of DCs
(Fig. S5 C and D). Similarly, unlike Pa- and TLR-pulsed DCs,
IL-4 treatment did not alter production of proinﬂammatory or
regulatory cytokines by SEA-exposed DCs. Thus, the inﬂuence of
IL-4 over DC activation is context dependent: IL-4 can enhance
TLR-driven IL-12p70 production, but engagement of these pat-
tern recognition receptors by deﬁned TLR ligands or bacteria can
also dramatically inhibit alternative activation markers ordinarily
induced by IL-4. In contrast, the helminth Ag SEA did not impede
this process.
Having demonstrated that DCs can express molecules asso-
ciated with aaMΦs in an IL-4Rα–dependent manner, and that
IL-4 can boost TLR-mediated proinﬂammatory cytokine pro-
duction, we next addressed the relevance of DC responsiveness
to IL-4 for T cell priming, one major characteristic used to dis-
tinguish DCs from MΦs. We have previously shown that Pa-ac-
tivated DCs generate a strong mixed Th1/Th17 response
following transfer into naive recipient mice (24). In contrast, we
have established that DCs pulsed with SEA are capable inducers
of Th2 responses both in vitro and in vivo, despite failing to up-
regulate traditional markers of activation (5). Although it has
been debated recently whether DCs are needed to prime Th2
responses (4), we have deﬁnitively shown that Th2 priming to
schistosomes is dependent on CD11c+ DCs (25).
To investigate whether DC responsiveness to IL-4 alters prim-
ing of naive T cells, we generated WT or Il4ra−/− DCs, exposed
them to Pa or SEA in vitro, then adoptively transferred them into
WT naive recipient mice, and compared Ag-speciﬁc immune
responses in the draining LN (dLN). Transfer of Pa pulsed Il4ra−/−
DCs resulted in signiﬁcantly lower amounts of Ag-speciﬁc IL-17
and IFNγ in recipient mice, in comparison with WT Pa DCs (Fig.
3A). This demonstrates that DC IL-4Rα signaling is required to
promote optimal T-cell responses even in a Th1/Th17 polarizing
environment with low levels of available Th2 cytokine. The de-
ﬁciency in IL-17 priming is unlikely to be due to alteration in DC
production of Th17-promoting cytokines IL-1β and IL-6, as IL-4
did not signiﬁcantly inﬂuence secretion of either of these cytokines
by DCs responding to Pa in vitro (Fig. S5E).
In the context of helminth- rather than bacterial Ag–condi-
tioned DCs, Il4ra−/− SEA DCs induced similar levels of Ag-
speciﬁc IL-4 and IL-13, but signiﬁcantly lower amounts of IL-10
and IFNγ in comparison with WT SEA DCs (Fig. 3B). This
indicates that DC expression of IL-4Rα is not an absolute re-
quirement for Th2 priming, but is needed for the induction of
IFNγ and IL-10 responses against SEA. In keeping with previous
work (26), the level of IL-17 induced by SEA-activated C57BL/6
DCs was negligible, and was not inﬂuenced by the presence or
absence of IL-4Rα on the transferred DCs.
The reduced ability of Il4ra−/− DCs to promote Pa-speciﬁc IL-
17 and IFNγ, and SEA-speciﬁc IL-10 and IFNγ, was not due to
a fundamental defect in Ag uptake, processing, or presentation
by these cells. Il4ra−/− DCs capably took up Ag in the form of
FITC-labeled dextran (Fig. S6), and displayed enhanced ability
to stimulate proliferation of OTII TCR Tg T cells in vitro, fol-
lowing exposure to ovalbumin (OVA) peptide or protein, com-
pared with WT DCs (Fig. S7).
IL-4 Alters the Response of DCs to CD40 Ligation. CD40 expressed by
DCs binds CD154 on the surface of activated T cells, this in-
teraction enhancing DC activation and cytokine production
which is often crucial for their ability to prime Th1, Th2 and
Th17 responses (24, 27). To address whether the IL-4 induced
alteration in the balance of IL-12, IL-10, RELMα, and Ym1/2
production by DCs might be inﬂuenced by interaction with T
cells we examined the impact of CD40 ligation on DC cytokine
production following IL-4 exposure. To mimic DC–T-cell in-
teraction in vitro, we analyzed cytokine secretion by DCs that
had previously been exposed to Pa or SEA in the presence of
absence of IL-4, after stimulation with agonistic αCD40 mAb.
IL-4 treatment of Pa-pulsed DCs signiﬁcantly enhanced pro-
Fig. 3. Il4ra−/− DCs are less able to induce IFNγ and IL-17 responses. WT or
Il4ra−/− BMDCs were cultured overnight in medium alone (M), with Pa (A) or
SEA (B), harvested, and injected s.c. into WT mice. Seven days later, the
draining pLN were harvested, cells were restimulated for 72 h with Pa (A) or
SEA (B), and cytokine secretion was assessed by ELISA. Data are representative
of ﬁve experiments. Error bars indicate SEM of three to ﬁve mice per group.









duction of IL-12p40, IL-6, and IL-12p70, and reduced secretion
of IL-10, following addition of αCD40 mAb (Fig. S8A). How-
ever, in keeping with previously published data (28), control
(medium) DCs or SEA DCs did not produce signiﬁcant amounts
of IL-12p70 or IL-10 following stimulation with anti-CD40, and
this was not inﬂuenced by IL-4 exposure (Fig. S8A). Therefore,
the inﬂuence of IL-4 on cytokine secretion by DCs responding to
bacterial stimulation was not transient, and extended to sec-
ondary activation via CD40 ligation.
Previous studies have suggested that RELMα and Ym1/2 may
have a role in regulating or promoting T-cell responses, respec-
tively (14, 21, 22), and it is conceivable that during T-cell priming,
CD154 expressed by T cells could engage DC CD40 and inﬂuence
secretion of these molecules. However, IL-4–treated DCs stimu-
lated with αCD40 mAb produced similar levels of RELMα and
Ym1/2 compared with isotype controls (Fig. S8B), indicating that
CD40 stimulation does not regulate IL-4–driven expression of
these alternative activation products either in control or SEA
DCs. Furthermore, in the case of Pa stimulated DCs, bacterial
inhibition of RELMα and Ym1/2 was maintained throughout
culture, and was not overcome by CD40 ligation (Fig. S8B). These
CD40 ligation experiments also illustrate that DCs previously
exposed to IL-4 still produced substantial amounts of RELMα and
Ym1/2 up to 36 h after initial cytokine treatment (Fig. S8B). Thus,
production of RELMα and Ym1/2 by DCs is not transient and
requires neither the continued presence of IL-4 nor subsequent
CD40 ligation.
DC Secretion of RELMα During Th2 Priming Regulates IFNγ and
Promotes Th2 Responses. Although our data demonstrate that DC
sensitivity to IL-4 plays an important role in priming of T-cell IL-
10, IL-17, and IFNγ (Fig. 3 A and B), it is not clear whether this is
a consequence of alternative activation marker expression or some
other facet of the diverse inﬂuence of IL-4 on DCs (Fig. 2 and Fig.
S5). To speciﬁcally address the role of a deﬁned alternative acti-
vation product in T-cell, priming we generatedDCs fromRetnla−/−
mice (20), which were similar to WT in terms of numbers and
phenotype. We adoptively transferred SEA- or Pa-pulsed WT or
Retnla−/− DCs into WT-naive recipient mice and assessed the
resulting Ag-speciﬁc immune response.
Retnla−/− Pa DCs induced similar IFNγ and IL-17 responses to
WT DCs in the draining LN following transfer (Fig. 4A), dem-
onstrating that DC-derived RELMα neither promotes nor reg-
ulates T-cell differentiation in a bacterial Th1/Th17 setting.
Thus, impaired priming by Il4ra−/− DCs exposed to bacteria (Fig.
3A) is RELMα independent. The lack of a major role for
RELMα in Th1/17 priming also ﬁts with the observed inhibition
of IL-4–induced RELMα expression by DCs following bacterial
or TLR ligand exposure (Fig. S5).
To directly assess the importance of DC RELMα secretion in
a Th2 setting, we transferred Retnla−/− DCs pulsed with SEA
into naive recipients. In repeated experiments, both WT and
Retnla−/− SEA DCs stimulated similar levels of Ag-speciﬁc IL-4,
but mice that received Retnla−/− DCs displayed signiﬁcantly re-
duced levels of IL-10 and IL-13 compared with WT SEA DCs
(Fig. 4B). Furthermore, Retnla−/− SEA DCs induced signiﬁcantly
greater amounts of IFNγ compared with WT SEA DCs (Fig. 4B).
This suggests that DC production of RELMα is required for
optimal Th2 cell priming by helminth-activated DCs, promoting
some components of the Th2 response while regulating the level
of the Th1 response.
To further dissect requirements for DC RELMα production in
promoting optimal T-cell Th2 cytokine secretion, we examined
the ability of WT or Retnla−/− DCs to induce CD4+ T-cell IL-4,
IL-10, and IL-13 in vitro. In this assay, the addition of exogenous
IL-4 to WT DCs cocultured with CD4+IL-10eGFP− T cells
puriﬁed from IL-10eGFP reporter mice (29), or CD4+ T cells
from KN2 mice in which IL-4–producing cells express huCD2
(30), resulted in induction of T-cell expression of eGFP or huCD2,
and secretion of IL-10 and IL-13 (Fig. 4 C andD). In keeping with
the lack of a signiﬁcant impact of RELMα deﬁciency on IL-4 in-
duction in vivo (Fig. 4B), Retnla−/−DCs capably provoked huCD2
expression on responding KN2 T cells in vitro (Fig. 4C). However,
Retnla−/− DCs were incapable of promoting T-cell expression of
IL-10 mRNA as detected by GFP expression (Fig. 4C). Further-
more, analysis of secreted cytokine by ELISA showed that cocul-
tures of CD4+ T cells and WT DCs produced more IL-10 and IL-
13 protein in the presence of IL-4 compared with cocultures with
Retnla−/− DCs (Fig. 4D). Interestingly, T cells cultured with WT
DCs secreted lower levels of IFNγ protein than their Retnla−/−
counterparts, supporting observations following in vivo DC
transfer of SEA activated DCs (Fig. 4B).
Fig. 4. DC expression of RELMα during Th2 priming regulates IFNγ and
promotes IL-10 and IL-13 production. WT or Retnla−/− BMDCs were cultured
overnight in medium alone (M), Pa (A), or SEA (B) and injected s.c. into WT
mice. Next, 5–7d later, pLN were harvested, cells were restimulated for 72 h
with Pa (A) or SEA (B), and cytokine secretion was assessed by ELISA. CD4+
cells sorted from KN2 IL-4 reporter mice, or IL-10eGFP−-CD4+ cells, were
cultured for 4 d with WT or Retnla−/− BMDCs and anti-CD3 mAb with or
without IL-4 and assessed for IL-4 protein production or IL-10 mRNA ex-
pression by ﬂow cytometry (C) and cytokine secretion by ELISA (D). Data are
representative of two (A and C) or four (B and D) experiments. Error bars
indicate SEM of three to ﬁve mice (A and B) or four to ﬁve replicate wells (C
and D) per group.
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Mechanistically, the altered ability of Retnla−/− DCs to po-
larize SEA-speciﬁc cytokine responses was not due to defective
Ag uptake, processing, or presentation by these cells. Similar to
Il4ra−/− DCs, Retnla−/− DCs competently took up Ag (Fig. S6),
and showed enhanced ability to induce proliferation of OTII
TCR Tg T cells in vitro (Fig. S7), with either OVA peptide or
protein. This increased proliferation is consistent with expecta-
tion, given the reduced IL-10 production evident following
transfer of Retnla−/− DCs in vivo (Fig. 4B) or coculture of
Retnla−/− DCs with T cells in vitro (Fig. 4 C and D).
These data strongly suggest that DC production of RELMα is an
important process both for directing priming of Th2 responses and
for control of Th1 responses, and provide mechanistic insight into
the function of RELMα during the early stages of T-cell
activation.
Discussion
A substantial body of literature documents the ability of IL-4 to
generate aaMΦs in multiple settings. However, comparatively
few studies have addressed how DCs respond to IL-4, whether
they can express markers associated with aaMΦs (11–14), and
what the functional relevance of this expression may be. The data
that we present here reveal that murine DCs can respond to IL-4
both in vitro and in vivo in a manner similar to that previously
described for aaMΦs, by signiﬁcantly up-regulating RELMα,
Ym1/2, and other aaMΦ markers, with the notable exception of
Arginase-1. Furthermore, we have identiﬁed that DC expression
of RELMα plays a critical role in their instruction of T cells to
produce IL-10 and IL-13. This demonstrates a previously unde-
scribed role for RELMα, and reveals that DC responsiveness to
IL-4 is vital for priming optimal Th2 responses.
Exposure of DCs to IL-4 triggered expression of numerous
markers associated with aaMΦ, but one notable difference was
the lack of Arginase-1 up-regulation at both the mRNA and
protein activity level. Arginase-1 competes with iNOS for L-ar-
ginine (6), and one consequence of increased Arginase-1 activity
is L-arginine depletion from the local environment. In murine
Leishmania major infection, increased arginase activity in para-
site-infected MΦs depletes the skin of L-arginine, impairing
proliferation of T cells in the lesion (31). Furthermore, MΦ-
derived Arginase-1 is required to suppress T-cell proliferation
during Th2 infection, where it limits pathology (8). The function
of DCs is instead mainly to prime naive T cells in the early phase
of immune response development. In this context, a high level of
Arginase-1 expression by immunogenic DCs that could deplete
L-arginine from the local environment might be undesirable.
In addition to RELMα and Ym1/2, we have found that IL-4–
treated DCs signiﬁcantly increased expression of Mrc1, Clec7a,
and Ccl24, all of which have previously been associated with
aaMΦs (6, 7). MR and Dectin-1 are both C-type lectin recep-
tors that can bind carbohydrates and trigger distinct signaling
pathways in DCs (32). MR has been linked mainly to in-
ternalization of Ags containing mannose motifs; however, in the
absence of an additional stimulus (such as TLR ligation), en-
gagement of the receptor is thought to be unable to mediate
proinﬂammatory responses in DCs (32). In contrast, Dectin-1
recognition of β glucans, which are mainly found in fungal cell
walls, initiates proinﬂammatory responses in DCs even in the
absence of TLR ligation (33). Our ﬁnding that IL-4 increases DC
expression of both these C-type lectin receptors suggests that they
will have an enhanced ability to internalize and respond to a wide
range of glycosylated pathogen motifs that could further modulate
their activation and function. Increased DC expression of CCL24
could also inﬂuence this process, as this chemokine can enhance
recruitment of CCR3-expressing cells such as eosinophils and
basophils, as has been reported for CCL24-producing aaMΦs in
the lung (34). These recruited granulocytes could, in turn, assist
Th2 priming in certain situations through provision of cytokines
such as IL-4.
As well as identifying that DCs can display hallmarks of al-
ternative activation following IL-4 exposure in vitro and in vivo,
we have revealed DC expression of alternative activation markers
in the context of chronic helminth infection, a subject that has so
far barely been addressed in the literature (11). There was some
heterogeneity in the levels of speciﬁc markers expressed when
comparing in vitro and in vivo settings, in particular with Ym1/2.
This could reﬂect basic differences between BMDCs and their
in vivo counterparts, or differential regulation of aspects of DC
alternative activation in vivo, in line with the well-documented
diversity of aaMΦs (6).
Our results also support and extend previously published work
addressing how IL-4 might alter the IL-12/IL-10 balance (15, 19),
but are unique in showing the impact of IL-4 on T-cell polariza-
tion by DCs in vivo. Our data highlight an important feedback
loop in DC-mediated priming in vivo, where sources of IL-4/IL-13
will not only promote Th2 responses (4), but will also facilitate
DC-mediated priming of Th1 responses through enhancement of
IL-12p70 and inhibition of IL-10 production by DCs. Extending
our understanding of the cross-talk between microbes, DCs, and
their environment, we have demonstrated the ability of deﬁned
TLR ligands and heat-killed bacteria to inhibit the ability of IL-4
to prompt RELMα and Ym1/2 production by DCs. In light of our
identiﬁcation of a pro-Th2 role for DC-derived RELMα, in-
hibition of such by bacteria or their products may be important in
some settings to allow optimal Th1/17 immunity to develop.
In peripheral environments, DCs migrate away from the site of
Ag exposure toward draining LNs (35). In order for RELMα and
Ym1/2 to play a relevant role in T-cell priming in the draining
LNs, DC expression of such molecules would have to be pro-
longed, or responsive to subsequent interaction with T cells. We
have shown that production of RELMα and Ym1/2 by DCs is not
transient and requires neither the continued presence of IL-4 nor
subsequent CD40 ligation. Furthermore, by adoptive transfer of
Retnla−/−DCs in vivo, we have identiﬁed a previously unreported
requirement for DC production of RELMα in the initiation of
Th2 responses in the LN draining the site of DC introduction.
A Th2-promoting role for RELMα contrasts with the down-reg-
ulatory role that has previously been described using global
Retnla−/− mice, which identiﬁed RELMα as a negative regulator
of ongoing Th2 inﬂammation against helminth Ag, with Retnla−/−
mice displaying elevated Th2 responses and greater pathology
(21, 22). These reports would suggest that the ultimate role for
RELMα produced by multiple cellular sources in vivo (including
eosinophils, epithelial cells, and MΦs) is to regulate chronic Th2
pathology by inﬂuencing T-cell differentiation and cellular re-
cruitment while regulating wound repair. In the present study, we
focused on the early events in Th2 priming by DCs in vitro and
in vivo. By restricting RELMα deﬁciency to DCs alone, our results
extend our fundamental understanding of the cellular, temporal,
and spatial diversity of RELMα function, demonstrating an al-
ternative function of DC expression of this molecule early in
immune response development. Our identiﬁcation of a critical
role for DC-derived RELMα in promotion of T-cell production of
IL-10 reveals a mechanism that may, in part, explain the dysre-
gulated immune pathology previously observed in Th2 infection
models using global Retnla−/− mice (21, 22).
It is clear from our results that RELMα production does not
solely account for Th2 induction by DCs, but helps promote
speciﬁc facets of this response (IL-10 and IL-13). Because we
have shown that IL-4 stimulates production or expression of
a wide range of alternative activation-related molecules in DCs,
and that Il4ra−/− and Retnla−/− DCs do not display identical
functional ability, it is likely that a combination of IL-4–induced
products will work together and in balance to ultimately dictate
the character of the resultant Th2 response. For example, as
Ym1/2 has previously been suggested to promote some Th2
cytokines, at least in vitro, its production by DCs responding to
IL-4 may act in concert with RELMα and other alternative ac-
tivation products to generate optimal Th2 immunity.
In summary, we have shown that the canonical Th2 cytokine
IL-4 can have a profound impact on DC activation and function,
triggering both in vivo and in vitro expression of a range of









molecules ordinarily associated with aaMΦs, altering responsive-
ness to challenge with bacteria and TLR ligands, and dramatically
inﬂuencing T-cell response induction and polarization. Although
the cumulative impact of IL-4 on DC activation and function is
complex, in the context of pathogenic stimulation, the over-riding
effect of IL-4 appears to be to enable IFNγ induction through
enhanced DC IL-12p70 production. Furthermore, DC production
of the IL-4 induced protein, RELMα, is important in priming of
T-cell IL-10 and IL-13. Together these ﬁndings indicate that IL-4
has a more inﬂuential and diverse role in directly regulating DC-
mediated T-cell priming than has been previously appreciated.
Materials and Methods
Mice and IL-4c Injections. C57BL/6, BALB/c, Retnla−/−, IL-10eGFPxDOG, KN2
(C57BL/6), Il4ra−/−, and OTII mice (20, 23, 25, 29, 30) were maintained under
speciﬁc pathogen-free conditions at the University of Edinburgh. Experi-
ments were conducted under a Project License granted by the Home Ofﬁce
(United Kingdom) in accordance with local guidelines. IL-4/anti-IL-4 mAb
complexes (IL-4c) were prepared as described previously (23). Mice were
injected i.p. with 50 μL PBS or 0.625–10μg IL-4 complexed to 11B11, and
peritoneal exudate cells (PEC) and spleens harvested 4 d later.
Cell Culture and DC Transfer. BM-derived DCs were generated with GM-CSF as
previously described (36). Following 10 d of culture, BMDCs were harvested
and replated at 2 × 106/mL for 18 h in the presence or absence of rIL-4 (20
ng/mL; Peprotech). In coculture experiments, CD4+GFP− T cells were sorted
from IL-10eGFPxDOG or KN2B6xB6 mice using BD FACs Aria-II and cultured
with WT or Retnla−/− DCs. For DC transfer, WT, Il4ra−/−, or Retnla−/− BMDCs
were cultured as above, with SEA, Pa, or medium alone. BMDCs were
injected s.c. into recipient WT mice (2.5 × 105 per foot) and 5–7d later the
draining popliteal LNs and restimulated as previously described (24, 36).
Supernatants were harvested after 72 h, and cytokine production was
assessed by ELISA. Further details are provided in SI Materials and Methods.
Flow Cytometry and ELISA. Details of mAb used are given in SI Materials and
Methods. Samples were acquired using FACS LSR II or FACS Canto II using BD
FACSDiva software and analyzed with FlowJo v.9 software (Tree Star). ELISAs
were performed on culture supernatants using paired mAb, and recombi-
nant cytokine standards, or DuoSets (eBioscience, BD Pharmingen, R&D
Systems, and Peprotech). Arginase assay details are provided in SI Materials
and Methods.
RNA Isolation and Quantitative PCR. RNAwas recovered from cells using TRIzol
(Invitrogen), cDNA was generated using SuperScript-III (Invitrogen). Relative
quantiﬁcation of the gene of interest was performed by quantitative PCR.
Primer details are given in SI Materials and Methods.
Statistical Analysis. Statistical analyses were carried out using GraphPad Prism
5. The Student’s t test or one-way analysis of variance was used to determine
signiﬁcant differences between sample groups (in ﬁgures, *P < 0.05 **P <
0.01 ***P < 0.001 ****P < 0.0001).
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